Single-Arm Phase II Survival Trial Design by Wu, Jianrong

Single-Arm Phase II Survival Trial Design (Hardcover) (ISBN-13: 9780367653453)

Vendor: Jianrong Wu
Product type: Books
Format: Hardcover
$190.00
$190.00
$190.00
Subtotal: $190.00
Single-Arm Phase II Survival Trial Design by Wu, Jianrong

Single-Arm Phase II Survival Trial Design

$190.00
Single-Arm Phase II Survival Trial Design by Wu, Jianrong

Single-Arm Phase II Survival Trial Design

$190.00
Format: Hardcover
Description
Description
x

Single-Arm Phase II Survival Trial Design provides a comprehensive summary to the most commonly- used methods for single-arm phase II trial design with time-to-event endpoints. Single-arm phase II trials are a key component for successfully developing advanced cancer drugs and treatments, particular for target therapy and immunotherapy in which time-to-event endpoints are often the primary endpoints. Most test statistics for single-arm phase II trial design with time-to-event endpoints are not available in commercial software.

Key Features:

  • Covers the most frequently used methods for single-arm phase II trial design with time-to-event endpoints in a comprehensive fashion.

  • Provides new material on phase II immunotherapy trial design and phase II trial design with TTP ratio endpoint.

  • Illustrates trial designs by real clinical trial examples

  • Includes R code for all methods proposed in the book, enabling straightforward sample size calculation.



    • Author: Jianrong Wu
    ISBN-10: 0367653451
    ISBN-13: 9780367653453
    Publisher: CRC Press
    Language: English
    Published: 07/20/2021
    Pages: 263
    Format: Hardcover
    Weight: 1.23lbs
    Size: 9.21h x 6.14w x 0.63d
By Jianrong Wu
By Jianrong Wu
x

Jianrong (John) Wu is a professor in the Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky; Biostatistics and Bioinformatics Shared Resource, Markey Cancer Center. Dr. Wu has more than 20 years' experience of designing and conducting cancer clinical trials at St. Jude Children's Research Hospital and Markey Cancer Center and has developed many novel statistical methods for designing and monitoring single-arm phase II and randomized phase III trial design with time-to-event endpoints.

Recently Viewed Products